Standard Chartered to Reduce Corporate Functions Roles by Over 15 in Pursuit of Higher Returns Chinese Investors Flock to Dividend Stocks Amid Limited Alternatives Market Not in a Bubble Analyst Suggests Wall Street Hasnt Adapted to New Market Dynamics Global Shares Rise Oil Prices Drop as Trump Indicates Progress in War Talks Bath Body Works Reports Q1 Sales Decline and Lower Adjusted Profit AI Consultants Charge Wall Street Banks 25000 Daily for Expertise Navios Maritime Partners NMM Q1 2026 Earnings Strong EPS Beat Amidst Market Headwinds BNT Q4 2024 Earnings Slight Profit Amid Quiet Quarter VTSI Q1 2026 Earnings EPS Surprises Slightly Above Estimates Despite Stock Decline Mesa Laboratories Inc MLAB Q1 2026 Earnings Stellar EPS Surprise of 130 Drives Optimism Amidst Quiet Revenue Period USCB Q1 2026 Earnings Earnings Beat Driven by Strong Net Interest Margin Team Inc Q1 2026 Earnings Adjusted Loss of 276 Per Share Amid Operational Challenges BT Brands Inc BTBD Edges Higher as Bullish Momentum Tests Key Resistance EVOXW Warrants Hover Near Support Amid Flat Trading Carnival Plc CUK Surges 656 as Cruise Demand Optimism Returns GE HealthCare Technologies GEHC Holds Steady Near Resistance Zone PIMCO Access Income Fund PAXS Edges Lower Amid Steady Trading Disneys The Mandalorian and Grogu Opens to LowestEver Star Wars Box Office Ainos Inc AIMD Q1 2025 Earnings Breakthrough Pipeline Progress Drives Massive Stock Surge Despite No Revenue Cardinal Infrastructure Group CDNL Drops 236 as Sector Rotation Weighs on Sentiment BLSH Q1 2026 Earnings EPS Misses Estimates Stock Declines 104 SHLS Q1 2026 Earnings EPS Beat Drives Stock Higher Amid Limited Revenue Disclosure NCNO Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Gains ACMR Q1 2026 Earnings EPS Surges 695 Above Estimates Shares Rally 55 STM Q1 2026 Earnings Earnings Miss Weighs on Results but Modest Stock Gain Suggests Broader Resilience Presidio Property Trust Q3 2023 Earnings Net Loss Widens as Real Estate Headwinds Persist PRLD Q1 2026 Earnings Narrower Loss Than Anticipated as Clinical Pipeline Advances